These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 7407434)
1. Radiation biology and potential therapeutic applications of radionuclides. Hofer KG Bull Cancer; 1980; 67(3):343-53. PubMed ID: 7407434 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic applications of Auger and alpha emitting radionuclides. Bloomer WD; McLaughlin WH; Adelstein SJ; Wolf AP Strahlentherapie; 1984 Dec; 160(12):755-7. PubMed ID: 6393458 [No Abstract] [Full Text] [Related]
3. Radioactive derivatives of 2-methyl-1, 4-naphthoquinol bis (diphosphate salt) as anti-cancer drugs with high LET radiations. Mitchell JS; Brown I; Carpenter RN Prog Clin Biol Res; 1984; 166():327-35. PubMed ID: 6504938 [TBL] [Abstract][Full Text] [Related]
4. Some considerations of physical and biological factors in radiotherapy with high-LET radiations including heavy particles, pi mesons, and fast neutrons. Tobias CA; Lyman JT; Lawrence JH Prog At Med; 1971; 3():167-218. PubMed ID: 5004402 [No Abstract] [Full Text] [Related]
12. The NCI All Ireland Cancer Conference. Johnston PG; Daly PA; Liu E Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862 [TBL] [Abstract][Full Text] [Related]
13. RBE of radiations in space and the implications for space travel. Edwards AA Phys Med; 2001; 17 Suppl 1():147-52. PubMed ID: 11771542 [TBL] [Abstract][Full Text] [Related]
14. A report on the implementation aspects of the International Atomic Energy Agency's first doctoral coordinated research project, "Management of liver cancer using radionuclide methods with special emphasis on trans-arterial radio-conjugate therapy and internal dosimetry". Padhy AK; Dondi M Semin Nucl Med; 2008 Mar; 38(2):S5-12. PubMed ID: 18243843 [TBL] [Abstract][Full Text] [Related]
15. Radioimmunotherapy with alpha-particle emitting radionuclides. Zalutsky MR; Pozzi OR Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):289-96. PubMed ID: 15640792 [TBL] [Abstract][Full Text] [Related]
16. Radiotargeting agents for cancer therapy. Kassis AI Expert Opin Drug Deliv; 2005 Nov; 2(6):981-91. PubMed ID: 16296803 [TBL] [Abstract][Full Text] [Related]
17. Strategies for selective targeting of Auger electron emitters to tumor cells. O'Donoghue JA J Nucl Med; 1996 Apr; 37(4 Suppl):3S-6S. PubMed ID: 8676202 [TBL] [Abstract][Full Text] [Related]
18. In vitro cytotoxicity of (211)at-astatide and (131)I-iodide to glioma tumor cells expressing the sodium/iodide symporter. Carlin S; Akabani G; Zalutsky MR J Nucl Med; 2003 Nov; 44(11):1827-38. PubMed ID: 14602867 [TBL] [Abstract][Full Text] [Related]
20. [Radionuclide therapy--a possible way toward an improved treatment of cancer. The obstacle is the shortage of commercially available radionuclides for clinical use]. Lundqvist H; Carlsson J; Gedda L; Tolmachev V; Garske U; Kairemo K Lakartidningen; 2004 Mar; 101(11):1000-2, 1005-6. PubMed ID: 15055121 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]